Innovative Black Researcher Pioneers Late-Stage Trials for Tuberculosis Vaccine

Tuberculosis (TB) remains a global health crisis, impacting 10.8 million people in 2023 and causing 1.25 million deaths. A promising vaccine, M72/AS01E, shows 50% efficacy in preventing pulmonary TB in latent cases. Dr. Alemnew Dagnew leads this vital research, aiming to protect vulnerable communities from TB's devastating effects.